Explore the full management transaction log of 명문제약, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 명문제약 has published 1 insider filings. Market capitalisation: €55.5bn. The latest transaction was reported on 29 April 2026 — Purchase. Among the most active insiders: 이영미. The full history is accessible without an account.